On the 30th of September, Wasatch Advisors bought 2.2 million Frequency Therapeutics, Inc. (FREQ) shares for $42 million at an average price of $19.21 per share. Shares of Frequency Therapeutics, Inc. are up 3.49% since the transaction.
Wasatch Advisors's holding in Frequency Therapeutics, Inc. increased to about 3.4 million shares with the purchase.
Wasatch Advisors first bought Frequency Therapeutics, Inc. stock in the fourth quarter of 2019. Wasatch Advisors also owns Medpace Holdings, Inc. (NASDAQ:MEDP), ICON Public Limited Company (ICLR), MacroGenics, Inc. (NASDAQ:MGNX) and ChemoCentryx, Inc. (NASDAQ:CCXI). Frequency Therapeutics, Inc. is its number three position by number of shares and market value among biotechnology & life sciences stocks.
Other investors who also added to their Frequency Therapeutics, Inc. shares include California State Teachers Retirement System. Contrary to Wasatch Advisors, Millennium Management and Victory Capital Management sold all their FREQ shares.
Wasatch Advisors also sold all their shares in MIND Technology, Inc. (MIND), Lonestar Resources US Inc. (NASDAQ:LONE) and One Stop Systems, Inc. (NASDAQ:OSS). The total value of the shares sold is estimated at around $16 million.
Additionally, Wasatch Advisors increased their share in Boot Barn Holdings, Inc. (NYSE:BOOT). The total value of the shares bought is estimated at around $69 million.